← Leaderboards
Kevin T Stroupe
Edward Hines Jr Va Hospital
$147,661
Attributed
$147,661
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $0 · FY2011–24$1$1$1$0$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$147,661 · 1
VA$0 · 4
By mechanism
R03$147,661 · 1
I01$0 · 3
I50$0 · 1
Top collaborators
- Frances M. Weaver2 shared
Most similar at Edward Hines Jr Va Hospital
Same institution · by research overlap
Others in their field
Top investigators on “Healthcare”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$310,647,775
- Lee Marshall Nadler · Dana-Farber Cancer Inst$231,641,351
- Larry Arthur$217,913,000
- Chanza Baytop · Westat, Inc.$200,838,189
- Steven E Reis · University Of Pittsburgh At Pittsburgh$131,443,914
- Mark R Farfel · Hugo W. Moser Res Inst Kennedy Krieger$119,981,780
Research focus
HealthcareCaringCollaborationsVeteransLeadershipOperationPharmacy BenefitPoliciesProviderBaseSurveysServicesSourceInterviewAffectOutpatientsPharmaceutical PreparationsDatabasesChronicDecision MakingMedication ComplianceChronic DiseaseCopaymentChicago
Grant awards (10)
Evidence to Policy Evaluation Center for Veterans (EPEC-Vet)$0
I50 · FY2024 · VA
Evidence to Policy Evaluation Center for Veterans (EPEC-Vet)$0
I50 · FY2024 · VA
Impact of the VA Medication Copayment Redesign$0
I01 · FY2022 · VA · contact PI
Impact of the VA Medication Copayment Redesign$0
I01 · FY2021 · VA · contact PI
Impact of the VA Medication Copayment Redesign$0
I01 · FY2020 · VA · contact PI
Impact of the VA Medication Copayment Redesign$0
I01 · FY2018 · VA · contact PI
Use of VA and Non-VA Health Care after the Affordable Care Act$0
I01 · FY2015 · VA · contact PI
Medication Self-Management Among Veterans Eligible for Medicare Part D$0
I01 · FY2011 · VA · contact PI
Cost-effectiveness of PTCA vs CABG in high-risk patients$73,912
R03 · FY2003 · HL
Cost-effectiveness of PTCA vs CABG in high-risk patients$73,749
R03 · FY2002 · HL